Ardelyx reported $1.41B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
Ardelyx USD 1.42B 89M Dec/2025
Corcept Therapeutics USD 3.66B 5.1B Dec/2025
Curis USD 3M 10M Apr/2026
Sanofi EUR 117.34B 2.45B Dec/2025
TG Therapeutics USD 4.73B 1B Dec/2025
United Therapeutics USD 20.98B 2.02B Dec/2025